# US 2004/0088765 A1 · Animal immunocontraceptives expressed in plants and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0088765 A1
- Document ID: US20040088765A1
- Status: Published application
- Kind: A1
- Application number: 10/664,118
- Filed: 2003-09-17
- Published: 2004-05-06
- Earliest claimed: 2002-09-19
- Inventors: G. Barrie Kitto; Daniel C. Hirschhora
- Web page: https://patentgrep.com/patent/US20040088765A1

## CPC

- A61K 39/0006: {Contraceptive vaccins; Vaccines against sex hormones}
- C12N 15/8258: {for the production of oral vaccines (antigens) or immunoglobulins}
- A61K 2039/517: {Plant cells}
- A61K 2039/542: {oral/gastrointestinal}
- A61K 2039/552: {Veterinary vaccine}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention provides immunocontraceptive vaccines comprising a genetically engineered plant that has been modified to produce the sperm-specific protein lactate dehydrogenase-C (LDH-C). When animals such as rodents eat this plant, their immune systems produce antibodies that attack their sperms. Not only would the males have less viable sperm, the females would also have antibodies to sperm entering their reproductive systems. Immunocontraception is an attractive method for reducing the population size of animals with high fecundity, and sterilizing animals using such immunocontraceptives can reduce targeted animal populations to acceptable levels in an efficient, cost-effective, humane and, importantly, a species-specific manner.

## Claims

### Claim 1

A genetically modified plant that expresses an immunocontraceptive comprising an egg-specific polypeptide or sperm-specific polypeptide.

### Claim 2 (depends on 1)

The genetically modified plant of claim 1, wherein said sperm-specific polypeptide is lactate dehydrogenase-C or an antigenic fragment thereof.

### Claim 3 (depends on 2)

The genetically modified plant of claim 2, wherein said lactate dehydrogenase-C is a rodent lactate dehydrogenase-C.

### Claim 4 (depends on 3)

The genetically modified plant of claim 3, wherein said rodent lactate dehydrogenase-C is a rat or mouse lactate dehydrogenase-C.

### Claim 5 (depends on 2)

The genetically modified plant of claim 2, wherein said antigenic fragment is selected from the group consisting of amino acids 5-17, 44-58, 61-77, 97-110, 180-210, 211-220, 231-243, 283-306, 307-316, and 101-115 of murine lactate dehydrogenase-C.

### Claim 6 (depends on 1)

The genetically modified plant of claim 1, wherein said plant is selected from the group consisting of potato, tobacco, corn, banana, wheat, rice, fruit, vegetable, legume, and grain crop.

### Claim 7 (depends on 1)

A method of decreasing the fertility of an animal, comprising the step of:
providing said animal the genetically modified plant of claim 1 thus allowing said animal to ingest the plant.

### Claim 8 (depends on 7)

The method of claim 7, wherein said animal is selected from the group consisting of mouse, rat, deer, elephants, water buffalo, feral horses, foxes, urban or wild dogs, urban or wild cats, rabbits, and other potentially overpopulated species causing economic damage to society.

### Claim 9

A genetically modified plant that expresses a sperm-specific polypeptide lactate dehydrogenase-C or an antigenic fragment thereof.

### Claim 10 (depends on 9)

The genetically modified plant of claim 9, wherein said lactate dehydrogenase-C is a rodent lactate dehydrogenase-C.

### Claim 11 (depends on 10)

The genetically modified plant of claim 10, wherein said rodent lactate dehydrogenase-C is a rat or mouse lactate dehydrogenase-C.

### Claim 12 (depends on 9)

The genetically modified plant of claim 9, wherein said antigenic fragment is selected from the group consisting of amino acids 5-17, 44-58, 61-77, 97-110, 180-210, 211-220, 231-243, 283-306, 307-316, and 101-115 of murine lactate dehydrogenase-C.

### Claim 13 (depends on 9)

The genetically modified plant of claim 9, wherein said plant is selected from the group consisting of potato, tobacco, corn, banana, wheat, rice, fruit, vegetable, legume, and grain crop.

### Claim 14 (depends on 9)

A method of decreasing the fertility of an animal, comprising the step of:
allowing said animal to ingest the genetically modified plant of claim 9.

### Claim 15 (depends on 14)

The method of claim 14, wherein said animal is selected from the group consisting of mouse, rat, deer, elephants, water buffalo, feral horses, foxes, urban or wild dogs, urban or wild cats, rabbits, and other potentially overpopulated species causing economic damage to society.
